Aromatase inhibitors have become essential in treating hormone-sensitive cancers, especially breast cancer. By effectively blocking estrogen synthesis, these drugs have reshaped the therapeutic landscape, offering improved disease management and patient outcomes. As research advances and pharmaceutical innovation accelerates, their relevance continues to grow globally. The development and...